Ignite Creation Date:
2024-05-19 @ 5:34 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06412588
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-25
First Post:
2024-05-09
Brief Title:
Dual Therapy With Vonoprazan Plus Amoxicillin or Doxycycline Versus Bismuth Quadruple Therapy for Helicobacter Pylori EradicationA Prospective Multicenter Open-label Randomized Controlled Study
Sponsor:
Nanjing First Hospital Nanjing Medical University
Organization:
Nanjing First Hospital Nanjing Medical University
Study Overview
Official Title:
Dual Therapy With Vonoprazan Plus Amoxicillin or Doxycycline Versus Bismuth Quadruple Therapy for Helicobacter Pylori EradicationA Prospective Multicenter Open-label Randomized Controlled Study
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
It is planned to select Hp infection patients in a number of tertiary hospitals in Jiangsu and randomly divide them into three groups group A is the classic group receiving Vonoprazan 20mg bid amoxicillin 10g bid doxycycline 01g bid colloidal pectin bismuth 03g bid and group C are double groups respectively receiving standard dose amoxicillin 10 g bid combined with vonorrasan dual regimen and doxycycline 01g bid combined with Vonoprazan dual regimen the treatment course of the three groups was 14 days and the oral dose of Vonoprazan was 20mg bid the eradication rate adverse reactions compliance and other aspects of the three groups were compared In order to obtain a safe efficient economical and convenient Hp eradication program with a wider range of applications
Detailed Description:
It is planned to select Hp infection patients in a number of tertiary hospitals in Jiangsu and randomly divide them into three groups group A is the classic group receiving Vonoprazan 20mg bid amoxicillin 10g bid doxycycline 01g bid colloidal pectin bismuth 03g bid and group C are double groups respectively receiving standard dose amoxicillin 10 g bid combined with vonorrasan dual regimen and doxycycline 01g bid combined with vonorrasan dual regimen the treatment course of the three groups was 14 days and the oral dose of Vonoprazan was 20mg bid the eradication rate adverse reactions compliance and other aspects of the three groups were compared In order to obtain a safe efficient economical and convenient Hp eradication program with a wider range of applications
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None